UnitedHealth Group (NYSE:UNH) Price Target Lowered to $610.00 at Truist Financial

UnitedHealth Group (NYSE:UNH) had its price objective trimmed by Truist Financial from $625.00 to $610.00 in a report published on Monday morning, Marketbeat Ratings reports. The firm currently has a buy rating on the healthcare conglomerate’s stock.

Other equities research analysts also recently issued reports about the company. Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Barclays upped their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Finally, HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $627.58.

UnitedHealth Group Trading Down 0.2 %

Shares of UnitedHealth Group stock opened at $511.95 on Monday. The company has a fifty day moving average of $558.76 and a 200 day moving average of $561.51. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $471.14 billion, a P/E ratio of 33.35, a P/E/G ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the company posted $6.56 EPS. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. M&T Bank Corp increased its holdings in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the period. Benjamin Edwards Inc. lifted its stake in shares of UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP purchased a new position in UnitedHealth Group in the third quarter valued at about $21,165,000. Discipline Wealth Solutions LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at about $558,000. Finally, Franklin Resources Inc. grew its position in shares of UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.